[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337301-105":59,"doc-detail-337301-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","chronic-inflammation-induced-by-escherichia-coli-blood-infections-as-a-risk-factor-for-pancreatic-cancer-progression","Chronic Inflammation Induced by Escherichia coli Blood Infections as a Risk Factor for Pancreatic Cancer Progression","","Pancreatic cancer shows high aggressiveness and mortality. The study evaluated 50 pancreatic cancer patients and 50 healthy family members and friends to determine whether Escherichia coli infection in bloodstreams relates to cancer progression through chronic inflammation. Serum biomarkers carbohydrate antigen 19-9 (CA19-9), amylase, procalcitonin (PCT), and interleukin-6 (IL-6) were measured, E. coli blood infection was detected using VITEK2, and antibiotic susceptibility was assessed. Elevated PCT and IL-6 indicated inflammation-linked tumor growth, invasion, and metastasis, while CA19-9 supported pancreatic cancer presence. Bloodstream infections were mainly caused by E. coli, with high resistance rates, and multidrug resistance was common.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chronic-inflammation-induced-by-escherichia-coli-blood-infections-as-a-risk-factor-for-pancreatic-cancer-progression/337301/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chronic-inflammation-induced-by-escherichia-coli-blood-infections-as-a-risk-factor-for-pancreatic-cancer-progression/337301.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study’s main aim?","Question",{"text":113,"@type":114},"To explore biomarkers (CA19-9, amylase, PCT, IL-6), confirm E. coli infection in patients’ bloodstreams, and evaluate how chronic inflammation affects pancreatic cancer progression.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which biomarkers were linked to chronic inflammation and cancer progression?",{"text":118,"@type":114},"Higher PCT and IL-6 levels in pancreatic cancer patients indicated chronic inflammation promoting tumor growth, invasion, and metastasis, while elevated CA19-9 supported pancreatic cancer presence.",{"name":120,"@type":111,"acceptedAnswer":121},"What proportion of bloodstream infections were caused by E. coli, and how resistant were the isolates?",{"text":122,"@type":114},"Most infections were caused by E. coli (34/50, 68%). Isolates showed 100% resistance to ciprofloxacin, approximately 94.11% resistance to levofloxacin and ceftazidime, and 85.2% multidrug resistance.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337301,1790633870,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","RESEARCH ARTICLE  \nEditorial Process: Submission:09/13/2024 Acceptance:12/17/2024  \nChronic Inflammation Induced by Escherichia coli Blood Infections as a Risk Factor for Pancreatic Cancer Progression Baraa Ahmed Saeed1, Anwer Jaber Faisal2 *, Bassam Shaker Mahmood3, Allaa Hatim Thanoon2  \nAbstract  \nBackground and Aim: Pancreatic cancer exhibits a high level of aggressiveness and is associated with a high mortality rate. The study comprised 50 patients with pancreatic cancer and 50 healthy family members and friends. The main goal is to explore the biomarkers carbohydrate antigen 19-9 (CA19-9), amylase, procalcitonin (PCT), and interleukin 6 (IL-6), confirm the presence of Escherichia coli infection in the patients’bloodstreams, and evaluate the effect of chronic inflammation on the progression of pancreatic cancer. Methods: The CA19-9, IL-6, and PCT levels of the control and patient groups were measured with Roche-Cobas C411, and their amylase levels were measured with Cobas C311 . In addition, a VITEK2 Compact system was utilized to detect E. coli blood infection, and the antibiotic susceptibility of the patients was evaluated. Results: The higher PCT and IL-6 levels (P \u003C 0.0001*) of the patients with pancreatic cancer indicated chronic inflammation promoting tumor growth, invasion, and metastasis, and high levels of CA19-9 (P \u003C 0.0001*) indicated pancreatic cancer. Moreover, tumor damage and ductal blockage lowered amylase levels in patients with pancreatic cancer. In addition, bloodstream infections in patients with pancreatic cancer were mostly caused byE. coli (34/50, 68%), and the isolates were resistant to ciprofloxacin (100%). Approximately, 94.11% were resistant to levofloxacin and ceftazidime, whereas only 26.4% were resistant to sulfamethoxazole/ trimethoprim. A total of 29 isolates (85.2%) were multidrug resistant. Conclusion: Chronic inflammation from E. coli infections is crucial to pancreatic cancer progression. Inflammatory indicators, including PCT and IL-6, and diagnostic biomarkers, including CA19-9 and amylase, reveal malignancy growth and bacterial infections that complicate treatment. Patients with positive PCT and IL-6 results were likely to have positive blood cultures andE. coli infections. These biomarkers should be utilized alongside other diagnostic imaging and biopsy methods to improve the detection of pancreatic cancer and screening for bacterial infections.  \nKeywords: Pancreatic cancer-Escherichia coli-PCT-Amylase-Antibiotic Resistance  \nAsian Pac J Cancer Prev, 25 (12), 4407-4414  \nIntroduction  \nPancreatic cancer is aggressive and fatal and has a poor prognosis . The common pancreatic cancer symptoms are yellow complexion, abdominal or back pain, unexplained weight loss, light-colored feces, dark urine, and loss of appetite. The early signs of the disease are usually absent, and pancreatic cancer symptoms usually appear in advanced stages. Pancreatic cancer usually already metastasizes at diagnosis [1] . Most pancreatic adenocarcinomas occur in people over 70, and few develop before the age of 40. Smoking, obesity, diabetes, and rare hereditary disorders increase pancreatic cancer risk. Smoking and hereditary genes cause 25% and 5%–10% of instances, respectively [2] .  \nApproximately 95% of pancreatic cancers originate in the exocrine pancreas, which produces digestive  \nenzymes [3]. Amylase, which is crucial for carbohydrate breakdown, is predominantly produced by the pancreas and salivary glands [4] . Pancreatic cancer frequently results in considerable structural harm to pancreatic tissues . Tumors can invade and disrupt the normal structure of the pancreas, which includes acinar cells that are important for the production of digesting enzymes, such as amylase [5] . The resulting damage diminishes the overall capability of the pancreas to generate these essential enzymes.  \nBloodstream infections (BSIs) are among the most challenging types of infections because they are difficult to manag","cbCaihmpSXFauQcG","https://ap.wps.com/l/cbCaihmpSXFauQcG","pdf",738055,"English","# Abstract\n## Background and Aim\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the study’s main aim?\",\"answer\":\"To explore biomarkers (CA19-9, amylase, PCT, IL-6), confirm E. coli infection in patients’ bloodstreams, and evaluate how chronic inflammation affects pancreatic cancer progression.\"},{\"question\":\"Which biomarkers were linked to chronic inflammation and cancer progression?\",\"answer\":\"Higher PCT and IL-6 levels in pancreatic cancer patients indicated chronic inflammation promoting tumor growth, invasion, and metastasis, while elevated CA19-9 supported pancreatic cancer presence.\"},{\"question\":\"What proportion of bloodstream infections were caused by E. coli, and how resistant were the isolates?\",\"answer\":\"Most infections were caused by E. coli (34/50, 68%). Isolates showed 100% resistance to ciprofloxacin, approximately 94.11% resistance to levofloxacin and ceftazidime, and 85.2% multidrug resistance.\"}]","Chronic Inflammation Induced by Escherichia coli Blood Infections as a Risk Factor for Pancreatic Cancer Progression | PDF",1790018521,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91bbba7d5d83ec5cd9e506497ec92eb1.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db290bd3201a55da74a5c5aa454cc93d.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97fd66e17856b22b2f778f9b0ef27b12.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53e4bd8701361af97fd4ce0db94e9f40.webp",980,1385]